M.DINA MARY; SHANTARAMAN KALYANARAMAN; DEEPADEVI .G; VASUKI MUTHURAMAN. Immunohistochemical loss of expression of estrogen receptor beta as a significant diagnostic marker in prostatic carcinoma. International Journal of Health and Clinical Research, [S. l.], v. 5, n. 2, p. 881–886, 2022. Disponível em: https://www.ijhcr.com/index.php/ijhcr/article/view/4957. Acesso em: 15 jun. 2026.